ReviewCells2022

Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: Progress, Challenges, and Prospects.

Shengjie Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.